Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04814342 · ClinicalTrials.gov registry record

Accuracy of Pulse Oximeters With Profound Hypoxia During Motion

A clinical trial of Hypoxia, sponsored by Nihon Kohden.

Completed
Registry status
5
Enrollment target
1
Study location

NCT04814342 is a study of Hypoxia that has completed, run by Nihon Kohden. The registered enrollment target is 5 participants, below the 3,117-participant average among 39 other Hypoxia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04814342, a study of Hypoxia, has completed, sponsored by Nihon Kohden.

COMPLETED
Registry status
5 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with patients during controlled motion.

Conditions Studied

Interventions

  • DEVICE Pulse oximeter

Study Locations (1)

California

  • UCSF Hypoxia Research Laboratory - San Francisco

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2021-03-24
Est. Completion 2022-02-15

Sponsor

Nihon Kohden

14 total trials

What the Registry Record Tells You About NCT04814342

The ClinicalTrials.gov registry entry for NCT04814342 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,117-participant average among 39 other Hypoxia trials with a reported enrollment target (100% lower). The listed sponsor is Nihon Kohden, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 1 intervention - of which Pulse oximeter is the first listed.

NCT04814342 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04814342 about?

NCT04814342 is a clinical study titled "Accuracy of Pulse Oximeters With Profound Hypoxia During Motion". The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with patients during controlled motion.

What is the current status of trial NCT04814342?

This trial is currently completed. The enrollment target is 5 participants. The study started on 2021-03-24. Estimated completion is 2022-02-15.

What conditions does trial NCT04814342 study?

This clinical trial studies the following conditions: Hypoxia.

What interventions are being tested in trial NCT04814342?

The interventions under investigation include: Pulse oximeter (DEVICE).

Who is sponsoring clinical trial NCT04814342?

This trial is sponsored by Nihon Kohden, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04814342 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.